Dr. Frezza Anna Maria

A Medical Oncologist since 2015, she has been employed since 2022 at the Medical Oncology 2, where she is part of the multidisciplinary team dedicated to sarcomas. She graduated and completed her residency at the Campus Bio-Medico University of Rome. During her training, she completed a clinical clerkship at the Dana-Farber Cancer Institute, Harvard Medical School – Center for Sarcoma and Bone Oncology (2008). 

In 2011–2012, she undertook two fellowships at the University College London Hospital – London Sarcoma Service and the Royal Marsden Hospital, during which she participated in and coordinated clinical and translational research projects in the field of sarcomas. In recognition of her contributions, she was awarded an honorary contract with University College London Hospital, which she held until 2014. 

Since joining the National Cancer Institute of Milan (2016–present), her clinical and research activities have focused on ultra-rare sarcomas. She has participated in and coordinated numerous national and international research projects in this field, resulting in more than 90 scientific publications. 

She collaborates with major national and international scientific societies, including the Italian Sarcoma Group (ISG), where she coordinates the working group on education and training, and ESMO, where she has been a member of the Sarcoma Faculty since 2021 and co-author of the sarcoma clinical practice guidelines. 

She has received several awards, including the CoE Training Fellowship from the European Neuroendocrine Tumour Society in 2015, the Annual Research Grant from the Umberto Veronesi Foundation in 2016, the Leaders Generation Programme Fellowship from ESMO in 2017, and the Young Investigator Award 2018 from the National Cancer Institute (INT) in 2019.